TREM2 and Alzheimer disease: Several of the top identified risk-conveying genes are highly enriched in myeloid cells (CR1, CD33, ABCA7, TREM2, MS4A, EPHA1, SPI14–6), highlighting the link between myeloid biology and the risk for developing AD.